相似文献
1
Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
J Clin Microbiol. 1995 Dec;33(12):3356-8. doi: 10.1128/jcm.33.12.3356-3358.1995.
2
3
Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Contrib Microbiol Immunol. 1995;13:331-3.
4
Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.
J Clin Microbiol. 2001 Oct;39(10):3541-7. doi: 10.1128/JCM.39.10.3541-3547.2001.
5
The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.
J Bacteriol. 2002 Aug;184(16):4489-99. doi: 10.1128/JB.184.16.4489-4499.2002.
6
Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
Zentralbl Bakteriol. 1998 Oct;288(2):277-91. doi: 10.1016/s0934-8840(98)80051-0.
7
Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
J Immunol. 1995 Jun 1;154(11):5896-906.
8
Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
FEBS Lett. 1996 Jul 22;390(2):196-8. doi: 10.1016/0014-5793(96)00656-4.
9
[Genotyping of Yersinia pseudotuberculosis isolated in Siberia and Far East].
Zh Mikrobiol Epidemiol Immunobiol. 2006 Sep-Oct(6):20-5.
10
Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
FEBS Lett. 1994 Dec 12;356(1):141-4. doi: 10.1016/0014-5793(94)01249-0.
引用本文的文献
1
infection with severe localised inflammation and ulceration of the ileum in a heart transplant patient.
BMJ Case Rep. 2020 Dec 13;13(12):e236343. doi: 10.1136/bcr-2020-236343.
2
Yersinia pseudotuberculosis infection in Kawasaki disease and its clinical characteristics.
BMC Pediatr. 2015 Nov 11;15:177. doi: 10.1186/s12887-015-0497-2.
3
Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in Human Yersiniosis.
J Pathog. 2011;2011:182051. doi: 10.4061/2011/182051. Epub 2011 Sep 12.
4
The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
PLoS Genet. 2007 Aug;3(8):e142. doi: 10.1371/journal.pgen.0030142. Epub 2007 Jul 10.
5
Linkage of the horizontally acquired ypm and pil genes in Yersinia pseudotuberculosis.
Infect Immun. 2005 Apr;73(4):2556-8. doi: 10.1128/IAI.73.4.2556-2558.2005.
6
The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.
J Bacteriol. 2002 Aug;184(16):4489-99. doi: 10.1128/JB.184.16.4489-4499.2002.
7
Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains.
J Clin Microbiol. 2001 Oct;39(10):3541-7. doi: 10.1128/JCM.39.10.3541-3547.2001.
8
Superantigen YPMa exacerbates the virulence of Yersinia pseudotuberculosis in mice.
Infect Immun. 2000 May;68(5):2553-9. doi: 10.1128/IAI.68.5.2553-2559.2000.
9
Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
J Clin Invest. 1997 Apr 15;99(8):1823-30. doi: 10.1172/JCI119349.
10
Homology with a repeated Yersinia pestis DNA sequence IS100 correlates with pesticin sensitivity in Yersinia pseudotuberculosis.
J Bacteriol. 1997 Mar;179(6):2081-5. doi: 10.1128/jb.179.6.2081-2085.1997.
本文引用的文献
1
2
Evidence for superantigen production by Yersinia pseudotuberculosis.
J Immunol. 1993 Oct 15;151(8):4183-8.
3
Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
FEBS Lett. 1994 Dec 12;356(1):141-4. doi: 10.1016/0014-5793(94)01249-0.
4
Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
J Immunol. 1995 Jun 1;154(11):5896-906.
5
6
Superantigens: bacterial and viral proteins that manipulate the immune system.
Annu Rev Cell Biol. 1993;9:101-28. doi: 10.1146/annurev.cb.09.110193.000533.
7
Acute renal failure associated with Yersinia pseudotuberculosis infection.
Nephron. 1995;70(3):319-23. doi: 10.1159/000188611.
8
Scarlatiniform rash and pleural effusion in a patient with Yersinia pseudotuberculosis infection.
J Pediatr. 1983 Jun;102(6):879-81. doi: 10.1016/s0022-3476(83)80016-x.
9
Community outbreak of Yersinia pseudotuberculosis.
Microbiol Immunol. 1984;28(8):883-91. doi: 10.1111/j.1348-0421.1984.tb00744.x.
10
Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome.
Pediatr Infect Dis. 1983 Mar-Apr;2(2):123-6. doi: 10.1097/00006454-198303000-00011.
Zotero 插件